GMO Payment Gateway, Inc (3RH) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of GMO Payment Gateway, Inc €52.14, price €46.20, upside +12.9%, quality 71 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
In Frankfurt, only 2 of the last 21 trading days (30 days) had any turnover. On the other days the price is an indicative quote without trading, so we do not list this stock in the radar. It stays reachable through search.
GPBroad dataSep 30, 2026
GMO Payment Gateway, Inc
3RH · F
UndervaluedQuality growthThe stock appears undervalued with acceptable quality.
Watch GMO Payment Gateway, Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 30, 2026.
How to read this chart
60‑month range €35.56 – €126.43 · fair‑value band €39.10 – €65.17 · the €46.20 price screens below the €52.14 fair value. Dashed = 300-day average. As of Sep 30, 2026.
Follow GMO Payment Gateway in your weekly email
Every Wednesday you see whether GMO Payment Gateway is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
GMO Payment Gateway, Inc., together with its subsidiaries, engages in the provision of payment related and financial services in Japan and internationally.
Show more
GMO Payment Gateway, Inc., together with its subsidiaries, engages in the provision of payment related and financial services in Japan and internationally. It offers online payment system, such as PG multi-payment service, a payment system that allows to select payment methods, such as credit card, carrier, bank transfer, payment after delivery, and CVS payment services; Ginko Pay Base System, a smartphone app that enables payments to be made by an immediate debit from the bank account; and GMO-PG processing platform, solutions for payment processing business. The company also provides face to face use services, including cashless platform, infrastructure of payment, and cooperation; pay payer system, such as paypay, d payment, Rakuten pay online payment, amazon pay, merpay, and AEON pay services; and business to business and buy now pay later services. In addition, it offers payment agency services in the online and recurring billing, and face-to-face field; banking as a service; lending; remittance; and instant salary receipt services. Further, the company provides marketing support services for listing ads that use Yahoo! Promotional advertising, and Google AdWords; and administrative services for Facebook Ads, Google Analytics, etc. Additionally, the company offers website analysis support, consulting, and other support services. The company was incorporated in 1995 and is headquartered in Tokyo, Japan.
Stock analysis
GMO Payment Gateway, Inc (3RH) currently trades at €46.20, while our model-based Fair Value estimate is €52.14, implying the stock looks roughly 11.4% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of €79.88 per share, and 13 of the 26 models we run sit above the €46.20 price.
Bear case: the Asset-Based group reads lowest at €5.62, and 13 of the 26 models stay below the price. Evidence for this calculation is high.
Scenario range: €39.10 (bear) to €65.17 (bull), the price of €46.20 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 71/100 (solid quality), in the Technology sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
GMO Payment Gateway, Inc reported revenue of ¥82.5B in FY2025 versus ¥50.3B in FY2022, a compound +17.9%/yr. Reported net income was ¥21.8B in FY2025, compounding −3.3%/yr from FY2022.
Key figures
Market cap €3.5B · P/E ratio 26.7 · P/S ratio 7.07 · EPS (TTM) €1.73 · Dividend yield 2.0% · Net margin 26.5% · Return on equity 21.7% · Return on assets (EBIT) 7.0%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 62 out of 100 (medium confidence).
What moves the price
The share trades about 17% below its 52-week high and 30% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Technology peers we cover trades at −23% fair-value upside, at 13%, 3RH screens cheaper than that median.
Fair Value models
Bear €39.10Fair Value €52.14Bull €65.17
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.100/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+11.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+17.9%
’22
’23
’24
’25
What shareholders gained per year (last 3 years), in JPY ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in JPY: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+7.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year+5.1%
Dividend (yield on the price)2.0%
Profit margin 2022 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.32% → 38%
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far and less than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−4.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+13.7%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in JPY, Japan: IMF forecast 2.1% a year to 2030, 1.3% from 2016 to 2025) that is about −6.3% a year for the price and +11.4% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (6 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.
Compare GMO Payment Gateway, Inc with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Software - Infrastructure · 332 stocks
Beats the industry median on 10/15 measures
Overall it ranks above its industry peers.
Valuation
Quality Score71 · Top 25%
Fair Value upside+12.9% · Above median
Profitability
Return on equity (TTM)21.7% · Top 25%
Return on assets5.8% · Above median
Net margin (TTM)27.7% · Top 25%
Operating margin (TTM)43.7% · Top 25%
Growth and dividend
Revenue growth16.8% · Above median
Dividend yield (TTM)2.0% · Above median
Balance sheet
Debt / equity0.26× · Above median
Valuation Multiplesvs Software - Infrastructure median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is GMO Payment Gateway, Inc (3RH) overvalued or undervalued?
As of Sep 30, 2026, our model estimates a fair value of €52.14 versus a price of €46.20, about +13% upside (undervalued).
What is the fair value of 3RH?
Our model-based fair value for GMO Payment Gateway, Inc is €52.14 (as of Sep 30, 2026), built from audited fundamentals. The current price: €46.20.
What is the quality score of 3RH?
GMO Payment Gateway, Inc has a Quality Score of 71/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for GMO Payment Gateway, Inc (3RH)?
Our model-based price target is the fair value of €52.14 (as of Sep 30, 2026) from 26 valuation models. Cautious scenario €39.10, optimistic scenario €65.17. It is a calculation from audited fundamentals, not an analyst target.
What is the GMO Payment Gateway, Inc stock forecast for 2026?
Our models put fair value at €52.14, about +13% upside versus a price of €46.20 (undervalued). Cautious scenario €39.10, optimistic scenario €65.17. The calculation is refreshed regularly with new filings.
What is the revenue of GMO Payment Gateway, Inc (3RH)?
GMO Payment Gateway, Inc reported trailing-twelve-month revenue of about ¥91.2B (latest available figure, as of Sep 30, 2026).
Does GMO Payment Gateway, Inc pay a dividend?
GMO Payment Gateway, Inc currently shows a dividend yield of about 1.96% relative to its recent price (as of Sep 30, 2026).
What growth is priced into GMO Payment Gateway, Inc (3RH)?
For today's price to be fair in a discounted-cash-flow model, GMO Payment Gateway, Inc would have to grow free cash flow by -4.3 % per year for five years (discount rate 9.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 3 years revenue grew +17.9 % per year. As of Sep 30, 2026.
What discount rate (WACC) does the fair value of 3RH use?
Our models discount GMO Payment Gateway, Inc at 9.8 %: a base by market capitalisation (mid), damped by beta 1.11, country premium for Germany. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For GMO Payment Gateway, Inc that is -4.3 % per year a year over ten years, using the same discount rate (9.8 %) and the same formula as our fair value.
How much growth has GMO Payment Gateway, Inc (3RH) delivered so far?
Over the past 3 years revenue at GMO Payment Gateway, Inc grew +17.9 % a year. The price currently implies -4.3 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of GMO Payment Gateway, Inc (3RH) growing?
The median revenue growth in the sector is +10.0 % a year. That is the yardstick for the growth priced into GMO Payment Gateway, Inc (-4.3 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of GMO Payment Gateway, Inc (3RH)?
The free-cash-flow yield on the price is 8.07 %: that much free cash flow GMO Payment Gateway, Inc produces per unit of market value. When it exceeds the discount rate of our models (9.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of GMO Payment Gateway, Inc (3RH)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For GMO Payment Gateway, Inc it is €52.14 per share (as of Sep 30, 2026), against a price of €46.20. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is GMO Payment Gateway, Inc stock overvalued or undervalued in 2026?
As of Sep 30, 2026, 3RH trades below its calculated fair value: price €46.20, fair value €52.14, a gap of about +13% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 3RH?
No. The price is what the market pays today (€46.20); the fair value is what the company's own numbers justify (€52.14). For GMO Payment Gateway, Inc the two are €5.94 per share apart. That gap is exactly why we show both numbers side by side.
How much is GMO Payment Gateway, Inc worth?
The market values GMO Payment Gateway, Inc at about €3.5B (market capitalisation, as of Sep 30, 2026). Per share that is €46.20; our models calculate a fair value of €52.14 per share.
What do the bullish and bearish scenarios say about 3RH?
Our models span a range for GMO Payment Gateway, Inc: cautious scenario €39.10, base €52.14, optimistic €65.17 per share (as of Sep 30, 2026, price €46.20). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 3RH?
GMO Payment Gateway, Inc trades at a price-to-earnings ratio of 26.7 (as of Sep 30, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €52.14 is built from several models across several years. Other multiples: PEG 2.5, P/B 5.5, P/S 6.8, EV/EBITDA 10.5.
What is the PEG ratio of 3RH?
The PEG ratio of GMO Payment Gateway, Inc is 2.50 (P/E divided by earnings growth, as of Sep 30, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of GMO Payment Gateway, Inc (3RH)?
Balance-sheet figures for GMO Payment Gateway, Inc (as of Sep 30, 2026): return on equity 21.7%, debt of 0.26 per unit of equity. They feed the Quality Score of 71/100, which measures business quality independently of the share price.
How far is 3RH from its 52-week high?
GMO Payment Gateway, Inc trades at €46.20, about 17% below its 52-week high of €55.50 and 30% above the low of €35.60 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of €52.14 is for.
Which stocks are comparable to GMO Payment Gateway, Inc?
From the same area (Technology) we also value Microsoft Corporation, Palantir Technologies Inc, Oracle Corporation, CrowdStrike Holdings, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is GMO Payment Gateway, Inc stock attractive at the current price?
The data as of Sep 30, 2026: price €46.20, calculated fair value €52.14 (+13%), Quality Score 71/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 3RH calculated?
We run GMO Payment Gateway, Inc through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €52.14, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. GMO Payment Gateway, Inc currently trades 11 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of GMO Payment Gateway, Inc (3RH)?
The closing price on Oct 1, 2026 was €46.20. Our model-based fair value is €52.14, about +13% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with GMO Payment Gateway, Inc right now?
The price sits in the lower half of our model range, the side with the larger margin of safety. The data supports the verdict: every model runs on fully documented inputs.
Key figures of GMO Payment Gateway, Inc
How large is the market capitalisation of GMO Payment Gateway, Inc (3RH)?
The market capitalisation of GMO Payment Gateway, Inc is €3.5B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of GMO Payment Gateway, Inc (3RH)?
The price-to-sales ratio of GMO Payment Gateway, Inc is 7.07 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of GMO Payment Gateway, Inc (3RH)?
Earnings per share at GMO Payment Gateway, Inc are €1.73 (price ÷ EPS = P/E 26.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of GMO Payment Gateway, Inc (3RH)?
The dividend yield of GMO Payment Gateway, Inc is 2.0% (payout 52.3%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of GMO Payment Gateway, Inc (3RH)?
The net margin of GMO Payment Gateway, Inc is 26.5% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of GMO Payment Gateway, Inc (3RH)?
The return on equity (ROE) of GMO Payment Gateway, Inc is 21.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of GMO Payment Gateway, Inc (3RH)?
On an EBIT basis the return on assets of GMO Payment Gateway, Inc is 7.0% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of GMO Payment Gateway, Inc (3RH)?
The operating margin of GMO Payment Gateway, Inc is 43.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at GMO Payment Gateway, Inc (3RH)?
Revenue at GMO Payment Gateway, Inc is growing +16.8% versus a year earlier (3y avg +17.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at GMO Payment Gateway, Inc (3RH)?
Earnings per share at GMO Payment Gateway, Inc are growing +21.2% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed
Watch GMO Payment Gateway, Inc in the live analysis
One click puts GMO Payment Gateway, Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
